These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1161 related articles for article (PubMed ID: 8850226)
1. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL; Saguier MC; Salamone HJ; Carreras LA Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires. Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867 [TBL] [Abstract][Full Text] [Related]
3. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey]. Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970 [TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province]. Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia. Ul-Hassan Z; Al-Bahrani AT; Panhotra BR Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814 [TBL] [Abstract][Full Text] [Related]
6. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation]. Christiansen CB Ugeskr Laeger; 1994 Dec; 156(51):7663-7. PubMed ID: 7839528 [TBL] [Abstract][Full Text] [Related]
7. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. Mangano AM; Remesar M; del Pozo A; Sen L J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282 [TBL] [Abstract][Full Text] [Related]
8. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Khameneh ZR; Baradaran M; Sepehrvand N Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311 [TBL] [Abstract][Full Text] [Related]
9. Is seroprevalence of HTLV-I/II among blood donors in India relevant? Kumar H; Gupta PK Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors. Kwon SY; Lim AH; Park JY; Han SH; Cho NS J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809 [TBL] [Abstract][Full Text] [Related]
11. Blood safety strategies for human T-cell lymphotropic virus in Europe. Laperche S; Worms B; Pillonel J; ; Vox Sang; 2009 Feb; 96(2):104-10. PubMed ID: 19076337 [TBL] [Abstract][Full Text] [Related]
12. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province]. Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004. Stramer SL; Foster GA; Dodd RY Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837 [TBL] [Abstract][Full Text] [Related]
14. [Prevalence of human T-lymphotropic virus, Type 1 and 2 in blood donors and patients with sexually transmissible diseases in Surinam]. Alberga H; Goubau P; Desmyter J; Carton H Ned Tijdschr Geneeskd; 1996 Aug; 140(33):1689-92. PubMed ID: 8830293 [TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina. de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703 [TBL] [Abstract][Full Text] [Related]
16. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant? Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617 [TBL] [Abstract][Full Text] [Related]
17. [Prevalence of HTLV-I/II infection among blood donors in Santa Fe Province, Argentina]. Brun RO; Astarloa L; Salomon HE; Biglione MM Medicina (B Aires); 2004; 64(2):125-8. PubMed ID: 15628298 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of HTLV-I/HTLV-II in blood donors in Buenos Aires (Argentina). Gutfraind Z; Blejer JL; Saguier MC; Gomez Carretero ML; Pirola DA; Carreras Vescio LA Vox Sang; 1994; 67(4):408-9. PubMed ID: 7701816 [No Abstract] [Full Text] [Related]
19. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of human T-cell leukemia virus types I and II in Switzerland. Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J; J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]